Who is sponsoring NCT03608930?

NCT03608930 is sponsored by Ningbo No. 1 Hospital.

What drugs are being tested in NCT03608930?

Interventions in NCT03608930: Disposable Polypectomy Snare,JHY-SD-23-230-30-A1.

What condition does NCT03608930 study?

NCT03608930 studies Polypectomy Snare.

Is NCT03608930 still recruiting?

NCT03608930 is currently completed. Last updated 2 July 2019.

Last reviewed 2019-07-02 · How we verify

NCT03608930

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Using Regular or Rotary Polypectomy Snare for the Resection of Colorectal Polyps

Completed NA Last updated 2 July 2019

What this trial tests

NA trial testing Disposable Polypectomy Snare,JHY-SD-23-230-30-A1 in Polypectomy Snare in 200 participants. Completed in 30 September 2018.

Timeline

1 August 2018

Primary endpoint
2 August 2018

30 September 2018

Quick facts

Lead sponsor	Ningbo No. 1 Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	1 August 2018
Primary completion	2 August 2018
Estimated completion	30 September 2018
Sites	1 location across China

Drugs / interventions tested

Disposable Polypectomy Snare,JHY-SD-23-230-30-A1

Conditions studied

Polypectomy Snare — all drugs for Polypectomy Snare →

Sponsor

Ningbo No. 1 Hospital

Who can join

Adults 18 to 85, any sex, with Polypectomy Snare. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial is being conducted to assess whether the rotary polypectomy snare could decrease the time to removal of colorectal polyps

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of Outcomes of Colorectal Polypectomy Using Traditional Snare and Rotary Snare: A Prospective Randomized Controlled Trial.
Xu L, Zhang Z, Xie J, Xu L, et al · · 2019 · cited 1× · PMID 31772572 · DOI 10.1155/2019/9123521

Verify or expand the search:

Other Ningbo No. 1 Hospital trials

Trials by the same sponsor.

NCT07181759 — Clinical Trial of VISOR vs fURS for Upper Urinary Tract Stone · NA · not yet recruiting
NCT07001865 — Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia · enrolling by invitation
NCT06984510 — Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population · recruiting
NCT06905795 — Screening and Intervention of MASLD in Children · NA · active not recruiting
NCT06987760 — Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03608930 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ningbo No. 1 Hospital
Last refreshed: 2 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03608930.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing